| MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer YJ Liang, QY Wang, CX Zhou, QQ Yin, M He, XT Yu, DX Cao, GQ Chen, ... Carcinogenesis 34 (3), 713-722, 2013 | 211 | 2013 |
| MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1 H Zhang, Q Wang, Q Zhao, W Di Journal of ovarian research 6, 1-9, 2013 | 133 | 2013 |
| HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation M He, QY Wang, QQ Yin, J Tang, Y Lu, CX Zhou, CW Duan, DL Hong, ... Cell Death & Differentiation 20 (3), 408-418, 2013 | 103 | 2013 |
| Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi X Xiong, Q Wang, S Wang, J Zhang, T Liu, L Guo, Y Yu, JD Lin Molecular metabolism 20, 128-137, 2019 | 92 | 2019 |
| The hepatokine Tsukushi gates energy expenditure via brown fat sympathetic innervation Q Wang, VP Sharma, H Shen, Y Xiao, Q Zhu, X Xiong, L Guo, L Jiang, ... Nature metabolism 1 (2), 251-260, 2019 | 67 | 2019 |
| MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer QY Wang, CX Zhou, MN Zhan, J Tang, CL Wang, CN Ma, M He, GQ Chen, ... Cell Death & Disease 9 (7), 752, 2018 | 59 | 2018 |
| MiR-630 suppresses breast cancer progression by targeting metadherin CX Zhou, CL Wang, AL Yu, QY Wang, MN Zhan, J Tang, XF Gong, QQ Yin, ... Oncotarget 7 (2), 1288, 2016 | 52 | 2016 |
| Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment P Zhang, Z Chen, H Kuang, T Liu, J Zhu, L Zhou, Q Wang, X Xiong, ... Cell metabolism 34 (9), 1359-1376. e7, 2022 | 38 | 2022 |
| The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility QY Wang, J Tang, CX Zhou, Q Zhao Sheng li xue bao:[Acta physiologica Sinica] 64 (4), 403-411, 2012 | 30 | 2012 |
| Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide H Shi, AA Gandhi, SA Smith, Q Wang, D Chiang, S Yalavarthi, RA Ali, ... JCI insight 6 (17), 2021 | 26 | 2021 |
| Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity I Çakır, CK Hadley, PL Pan, RA Bagchi, M Ghamari-Langroudi, DT Porter, ... Nature metabolism 4 (1), 44-59, 2022 | 25 | 2022 |
| Uncoupling exercise bioenergetics from systemic metabolic homeostasis by conditional inactivation of Baf60 in skeletal muscle ZX Meng, W Tao, J Sun, Q Wang, L Mi, JD Lin Diabetes 67 (1), 85-97, 2018 | 17 | 2018 |
| The hepatokine TSK maintains myofiber integrity and exercise endurance and contributes to muscle regeneration Q Wang, X Qiu, T Liu, C Ahn, JF Horowitz, JD Lin JCI insight 7 (4), 2022 | 6 | 2022 |
| Deletion of the feeding-induced hepatokine TSK ameliorates the melanocortin obesity syndrome Q Wang, P Zhang, I Cakir, L Mi, RD Cone, JD Lin Diabetes 70 (9), 2081-2091, 2021 | 6 | 2021 |
| Intrahepatic paracrine signaling by cardiotrophin‐like cytokine factor 1 ameliorates diet‐induced NASH in mice T Liu, Q Wang, L Zhou, P Zhang, L Mi, X Qiu, Z Chen, H Kuang, S Li, ... Hepatology 78 (5), 1478-1491, 2023 | 3 | 2023 |
| TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2 QZ Cixiang Zhou 1, Difei Wang 1, Jingchi Li 1, Qiuyu Wang 1, Lulu Wo 1, Xin ... | | 2022 |
